[{"AccountsPayableCurrent_0_Q3_USD":8900000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0,"PaymentsToAcquireProductiveAssets_3_Q3_USD":2962000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":104774000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":8606000.0,"OtherPrepaidExpenseCurrent_0_Q3_USD":9943000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":771000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-166000.0,"OtherNoncashIncomeExpense_3_Q3_USD":-35000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":2609000.0,"OtherDepreciationAndAmortization_3_Q3_USD":4551000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-33000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":6000.0,"OtherAssetsNoncurrent_0_Q3_USD":3297000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":1830000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":40718000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":54353000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1016000.0,"OperatingIncomeLoss_3_Q3_USD":-201617000.0,"OperatingIncomeLoss_1_Q3_USD":-53615000.0,"OperatingExpenses_3_Q3_USD":241982000.0,"OperatingExpenses_1_Q3_USD":66809000.0,"NetIncomeLoss_3_Q3_USD":-167392000.0,"NetIncomeLoss_1_Q3_USD":-35308000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-165424000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":113670000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":91711000.0,"LongTermDebt_0_Q3_USD":615867000.0,"PreferredStockSharesAuthorized_0_Q3_shares":230000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockValue_0_Q3_USD":null,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":73574000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":67945000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_3_Q3_USD":5000.0,"StockIssuedDuringPeriodValueNewIssues_3_Q3_USD":108180000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_3_Q3_USD":2862000.0,"StockholdersEquity_0_Q3_USD":-323592000.0,"ShareBasedCompensation_3_Q3_USD":45143000.0,"SeveranceCosts1_1_Q3_USD":1771000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":77780000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":21299000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":40365000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":13194000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-1694009000.0,"LiabilitiesCurrent_0_Q3_USD":66082000.0,"RestructuringReserveAccrualAdjustment1_3_Q3_USD":1771000.0,"RestructuringCharges_3_Q3_USD":1771000.0,"RestructuringCharges_1_Q3_USD":1771000.0,"RestrictedCashNoncurrent_0_Q3_USD":833000.0,"RestrictedCash_0_Q3_USD":833000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":162431000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":43739000.0,"RepaymentsOfNotesPayable_3_Q3_USD":10730000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":16003000.0,"ProceedsFromStockPlans_3_Q3_USD":2862000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":5000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_3_Q3_USD":6000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3_Q3_USD":221400000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":108180000.0,"RestructuringReserve_0_Q3_USD":1771000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":403109000.0,"InterestPayableCurrent_0_Q3_USD":5808000.0,"InterestPaidNet_3_Q3_USD":25967000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-167425000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-35302000.0,"CommonStockValue_0_Q3_USD":1000.0,"CommonStockSharesOutstanding_0_Q3_shares":73698000.0,"CommonStockSharesIssued_0_Q3_shares":73698000.0,"CommonStockSharesAuthorized_0_Q3_shares":200000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":39957000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":122257000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":121424000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":94789000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":185624000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":2902000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":185614000.0,"AssetsCurrent_0_Q3_USD":297172000.0,"Assets_0_Q3_USD":403109000.0,"AreaOfRealEstateProperty_0_Q3_sqft":8000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":14983000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":15576000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":45143000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":14370000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":45143000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":14370000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":8606000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q3_USD":2286000.0,"AdditionalPaidInCapital_0_Q3_USD":1370402000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":14000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":10000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":67945000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":320000.0,"DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax_0_Q3_USD":0.0,"InterestExpense_3_Q3_USD":35227000.0,"InterestExpense_1_Q3_USD":11742000.0,"IncreaseDecreaseInPrepaidExpensesOther_3_Q3_USD":99000.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":1006000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_3_Q3_USD":776000.0,"IncreaseDecreaseInOperatingLeaseLiability_3_Q3_USD":443000.0,"IncreaseDecreaseInInterestPayableNet_3_Q3_USD":1834000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-8648000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":-36573000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":2206000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":0.0,"IncomeTaxExpenseBenefit_1_Q3_USD":-7000.0,"IncomeTaxesPaidNet_3_Q3_USD":-3814000.0,"ConvertibleLongTermNotesPayable_0_Q3_USD":227767000.0,"IncomeLossFromEquityMethodInvestments_3_Q3_USD":68681000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-167392000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-35315000.0,"FinanceLeaseRightOfUseAssetAmortization_3_Q3_USD":2758000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q3_USD":0.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"EquityMethodInvestments_0_Q3_USD":45086000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":8635000.0,"EarningsPerShareDiluted_3_Q3_USD":-2.46,"EarningsPerShareDiluted_1_Q3_USD":-0.48,"EarningsPerShareBasic_3_Q3_USD":-2.46,"EarningsPerShareBasic_1_Q3_USD":-0.48,"DueFromRelatedPartiesCurrent_0_Q3_USD":43773000.0,"DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries_0_Q3_USD":0.0,"IncomeLossFromEquityMethodInvestments_1_Q3_USD":30208000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":73574000.0,"Ticker":"TBPH","CIK":"1583107","name":"THERAVANCE BIOPHARMA, INC.","OfficialName":"Theravance Biopharma Inc. Ordinary Shares","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"688048421.0","Country":"Cayman Islands","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211108"}]